EAACI Congress 2024
BackFT 02 - Flash talks on Asthma
Friday 31 May, 08:30 AM -
10:00 AM Valencia, Spain
Cordoba
Flash Talks
08:30
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
08:37
Probiotics Supplementation on mitigating adverse effects of Phthalate-Induced Asthma
08:44
Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber
08:51
Granulocytic myeloid derived suppressive cells exacerbate disease status in bronchiectasis
08:58
Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis
09:05
Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype
09:12
Prevalence of severe fatigue and its contributing factors in patients with severe asthma
09:19
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
09:26
Reduced Allergic Asthma By Soy And Its Potential Mechanism Via Plasminogen Activator Inhibitor-1
09:33
Comparison of the efficacy of omalizumab and mepolizumab in non-steroidal anti-inflammatory drug-exacerbated respiratory disease
09:33
Serum Periostin Level Predicted Length of Hospital Stay in Patients with Allergic Asthma
09:40
The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies
